=> To understand the principles of the analytical methods, HPLC, GLC, RIA, and EMIT
=> To describe and understand how changes in physiology effect the pharmacokinetics of drugs in the very young and the elderly
We can start this topic by talking about the Clinical Pharmacy service, Therapeutic Drug Monitoring. This involves the measurement and interpretation of plasma/serum/blood concentrations in patients.
a) the drug has a narrow therapeutic-toxic range,
b) there is a large variability in pharmacokinetic parameter values between patients,
c) the therapeutic effect is not readily assessed (e.g. antibiotics) or clinical symptoms are to be avoided (e.g. seizure). Not as useful for blood pressure lowering (can measure B.P. directly) or anticoagulants (again measure clotting time directly),
d) there is a direct relationship between Cp or concentration in other biological sample (e.g. saliva) and pharmacological effect,
e) an appropriate (accurate, short turn around, inexpensive) analytical method is available for the drug,
f) the expected or desired therapeutic effect is not observed (may be absorption or compliance problem),
g) a drug with high first pass effect is involved, or
h) a patients has altered and/or variable renal state and the drug is eliminated mostly as unchanged drug in urine (fe less than 1)
Drug | Therapeutic Concentration Range |
Aminoglycoside (gentamicin, tobramycin) | 0.5 <-> 8 mg/L |
Digoxin | 0.5 <-> 8 2.0 ug/L |
Phenytoin | 10 <-> 8 20 mg/L |
Theophylline | 10 <-> 8 20 mg/L |
Information required
Organize sample collection and analysis
Accurate Timing in necessary
Figure XXI-1. Illustrating the Effect of Sample Times on Parameter Values
Evaluate pharmacokinetically the analytical result and recalculate dosing regimen recommendations
Organize further samples if necessary, repeat as necessary
Copyright 2001 David W.A. Bourne